Somerset, NJ, USA
Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
October 14, 2024 06:00 ET | Ardena Holding NV.
Ardena acquires Catalent's Somerset, NJ facility, expanding its US presence and boosting advanced oral drug product manufacturing capabilities.
Nucleic Acid Therapeutics CDMO Market
Nucleic Acid Therapeutics CDMO Industry Outlook, 2024-2030 - Increasing Demand for One-Stop-Shop CDMOs and Growing FDIs in Nucleic Acid Therapeutics
October 10, 2024 12:30 ET | Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The...
Curia_logo_color_CMYK_updated.jpg
Curia Commits to SBTi Net-Zero Standard
October 08, 2024 09:00 ET | Curia Global, Inc.
Curia today announced its commitment to set near- and long-term greenhouse gas reductions in line with the Science Based Targets initiative (SBTi).
Curia_logo_color_CMYK_updated.jpg
Curia Unveils Brand Refresh at CPHI WW in Milan
October 07, 2024 09:49 ET | Curia Global, Inc.
Curia refreshes its brand with an updated brand hierarchy, refined messaging and revamped website, highlighting its key capabilities.
RTI logo.png
RTI Surgical Announces Agreement to Acquire Collagen Solutions
October 07, 2024 07:00 ET | RTI Surgical
RTI Surgical Announces Agreement to Acquire Collagen Solutions Further expands RTI’s soft tissue portfolio of xenograft and allograft materials at scaleImproves access to high-growth cardiac,...
Oct 7 - Sustainability Pic
Sai Life Sciences releases Sustainability Report 2024
October 07, 2024 05:03 ET | SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
October 04, 2024 07:30 ET | Lifecore Biomedical, Inc.
-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 -- -- Signed Multiple New Business Agreements with New and Existing Customers -- -- More than Doubled Capacity with Installation of 5-Head...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
October 04, 2024 07:20 ET | Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing...
22157.jpg
M&A in the Pharma Contract Manufacturing Industry: 2024 Trends, Implications and Outlook
October 04, 2024 05:00 ET | Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "M&A in the Contract Manufacturing Industry: Implications and Outlook - 2024 Edition" report has been added to ResearchAndMarkets.com's...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
October 03, 2024 16:05 ET | Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...